Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality.
dalbavancin
effectiveness
gram-positive
hospital stay
methicillin-resistant Staphylococci
mortality
multidrug-resistant gram-positive cocci
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
24 Oct 2021
24 Oct 2021
Historique:
received:
27
09
2021
revised:
17
10
2021
accepted:
18
10
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
Dalbavancin is a new antibiotic that is effective against Gram-positive microorganisms, including methicillin-resistant
Identifiants
pubmed: 34827234
pii: antibiotics10111296
doi: 10.3390/antibiotics10111296
pmc: PMC8614661
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Anaesthesiol Intensive Ther. 2019;51(2):107-111
pubmed: 31268271
Int J Antimicrob Agents. 2020 Dec;56(6):106210
pubmed: 33223119
Int J Infect Dis. 2019 Apr;81:210-214
pubmed: 30794940
Diagn Microbiol Infect Dis. 2019 Mar;93(3):213-218
pubmed: 30396697
BMC Infect Dis. 2014 Nov 28;14:92
pubmed: 25431211
Open Forum Infect Dis. 2019 Jun 05;6(7):ofz274
pubmed: 31281868
GMS Infect Dis. 2019 Oct 23;7:Doc03
pubmed: 31728264
Ann Clin Microbiol Antimicrob. 2019 Oct 19;18(1):30
pubmed: 31629409
PLoS One. 2017 Nov 14;12(11):e0187792
pubmed: 29136035
Pharmacotherapy. 2020 May;40(5):469-478
pubmed: 32239771
N Engl J Med. 2014 Jun 5;370(23):2169-79
pubmed: 24897082
Infect Dis Ther. 2019 Jun;8(2):171-184
pubmed: 31054088
Clin Drug Investig. 2021 May;41(5):437-448
pubmed: 33884583
Clin Infect Dis. 2011 Feb 1;52(3):285-92
pubmed: 21217178
J Antimicrob Chemother. 2019 Aug 1;74(8):2405-2416
pubmed: 31322694
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Open Forum Infect Dis. 2018 Dec 10;6(1):ofy331
pubmed: 30648126
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30858217
Infect Dis Ther. 2021 Mar;10(1):471-481
pubmed: 33515414
Clin Infect Dis. 2005 Nov 15;41(10):1407-15
pubmed: 16231250
Int J Antimicrob Agents. 2018 Apr;51(4):571-577
pubmed: 29180276
Clin Microbiol Infect. 2018 Apr;24(4):361-368
pubmed: 28882727
Infect Dis Ther. 2020 Mar;9(1):53-67
pubmed: 31713130